Mitomycin medac


Mitomycin C (MMC) is an effective cytostatic agent used in the treatment of patients with gynecological malignancies and breast carcinoma.Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors.Liver Metastases of Neuroendocrine Tumors: Treatment With. of hepatic transarterial chemotherapy using two therapeutic protocols. mitomycin C, Medac.

Antitumor antibiotics are made from natural products produced by species of the.The use of Mitomycin C:. treated with Mitomycin C 0.02 % (Medac.

frühinstillation medac gmbh von medac de embed share

Chemotherapeutic drug sensitivity of primary cultures of epithelial ovarian cancer cells from patients in relation to tumour characteristics and therapeutic outcome.Expert-reviewed information summary about the treatment of bladder cancer.

Pełnej informacji o leku udziela:

This eMedTV article explains how BCG bladder cancer treatment is often combined with biological therapy.

The BCG-medac powder was re-suspended with 50 ml of 0.9% normal and introduced into the bladder.

Leki oryginalne, wysyłane z polski bez recepty, dyskretnie i szybko


Treosulfan is a substance that is being studied in the treatment of cancer.The invention relates to a method for producing freeze-dried mitomycin C. dried pharmaceutical composition having a.To diagnose bladder cancer, your doctor completes a thorough medical history and examination.<